Multi-task deep learning for risk stratification and shared molecular architecture of cardiometabolic multimorbidity under fragmented multi-omics
Abstract Cardiometabolic multimorbidity (CMM) reflects a systemic failure of interconnected physiological networks, yet current risk stratification approaches based on macroscopic clinical phenotypes leave substantial molecular residual risk unresolved. Although multi-omics integration offers a means to capture this latent vulnerability, its population-scale application is limited by pervasive fragmentation and non-overlapping availability of proteomic and metabolomic data. Here, we develop the Multi-Omics Perceiver for Survival (MOP-Surv), a deep learning framework designed to accommodate incomplete multi-omics profiles without imputation through dynamic attention masking and multi-task survival learning. Applied to 297,067 UK Biobank participants, MOP-Surv achieved consistent risk stratification across six cardiometabolic endpoints and provided modest incremental predictive value. Beyond prediction, MOP-Surv identified a hierarchical structure of cross-endpoint prognostic associations and highlighted a parsimonious set of biomarkers including GDF15, EDA2R, and WFDC2 with consistent prognostic relevance across diverse disease trajectories. Therefore MOP-Surv provides a practical approach for integrating fragmented multi-omics data to characterize shared prognostic patterns across cardiometabolic outcomes.
Authors
- Xinran Qiao (ORCID: https://orcid.org/0000-0002-0354-3364)
- Liangshen Cao
- Jianing Wang
- Hongpeng Sun
- Shuaihong You
- Guangying Yue
- Liyuan Han
- Xiaole Zhu
Institutions
- Jiangsu University (CN)
- Soochow University (CN)
- Shenzhen Sixth People's Hospital (CN)
- Ningbo No. 2 Hospital (CN)
- First People's Hospital of Kunshan (CN)
- Ningbo No.6 Hospital (CN)
- Ningbo Institute of Industrial Technology (CN)
Publication Details
- Journal
- BMC Bioinformatics
- Published
- 2026-08-24
- DOI
- https://doi.org/10.1186/s12859-026-06614-w
- Primary Topic
- GDF15 and Related Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00